Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of DKK 206.90 billion. The enterprise value is 230.53 billion.

Market Cap	206.90B
Enterprise Value	230.53B

Important Dates

The next estimated earnings date is Tuesday, November 5, 2024.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	May 13, 2024

Share Statistics

Coloplast has 224.84 million shares outstanding. The number of shares has increased by 5.87% in one year.

Shares Outstanding	224.84M
Shares Change (YoY)	+5.87%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	5.72%
Owned by Institutions (%)	24.27%
Float	141.99M

Valuation Ratios

The trailing PE ratio is 41.65 and the forward PE ratio is 34.58. Coloplast's PEG ratio is 3.43.

PE Ratio	41.65
Forward PE	34.58
PS Ratio	7.86
PB Ratio	12.52
P/FCF Ratio	137.84
PEG Ratio	3.43

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.63, with an EV/FCF ratio of 153.59.

EV / Earnings	46.41
EV / Sales	8.76
EV / EBITDA	27.63
EV / EBIT	32.01
EV / FCF	153.59

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 148.41.

Current Ratio	0.85
Quick Ratio	0.53
Debt / Equity	148.41
Debt / EBITDA	2.94
Debt / FCF	16.34
Interest Coverage	9.13

Financial Efficiency

Return on equity (ROE) is 43.17% and return on invested capital (ROIC) is 12.92%.

Return on Equity (ROE)	43.17%
Return on Assets (ROA)	10.76%
Return on Capital (ROIC)	12.92%
Revenue Per Employee	1.64M
Profits Per Employee	310,069
Employee Count	15,692
Asset Turnover	0.63
Inventory Turnover	2.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.22% in the last 52 weeks. The beta is 0.32, so Coloplast's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+17.22%
50-Day Moving Average	882.87
200-Day Moving Average	852.36
Relative Strength Index (RSI)	56.43
Average Volume (20 Days)	197,682

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of DKK 26.30 billion and earned 4.97 billion in profits. Earnings per share was 22.09.

Revenue	26.30B
Gross Profit	17.76B
Operating Income	7.20B
Pretax Income	6.32B
Net Income	4.97B
EBITDA	8.08B
EBIT	7.20B
Earnings Per Share (EPS)	22.09

Full Income Statement

Balance Sheet

The company has 887.00 million in cash and 24.52 billion in debt, giving a net cash position of -23.64 billion or -105.13 per share.

Cash & Cash Equivalents	887.00M
Total Debt	24.52B
Net Cash	-23.64B
Net Cash Per Share	-105.13
Equity (Book Value)	16.52B
Book Value Per Share	73.49
Working Capital	-1.83B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.60 billion and capital expenditures -1.10 billion, giving a free cash flow of 1.50 billion.

Operating Cash Flow	2.60B
Capital Expenditures	-1.10B
Free Cash Flow	1.50B
FCF Per Share	6.68

Full Cash Flow Statement

Margins

Gross margin is 67.52%, with operating and profit margins of 27.38% and 18.88%.

Gross Margin	67.52%
Operating Margin	27.38%
Pretax Margin	24.02%
Profit Margin	18.88%
EBITDA Margin	30.73%
EBIT Margin	27.38%
FCF Margin	5.71%

Dividends & Yields

This stock pays an annual dividend of 21.00, which amounts to a dividend yield of 2.28%.

Dividend Per Share	21.00
Dividend Yield	2.28%
Dividend Growth (YoY)	5.00%
Years of Dividend Growth	11
Payout Ratio	95.03%
Buyback Yield	-5.87%
Shareholder Yield	-3.59%
Earnings Yield	2.40%
FCF Yield	0.73%

Dividend Details

Stock Splits

The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.

Last Split Date	Dec 19, 2012
Split Type	Forward
Split Ratio	5